Abstract:Human pluripotential embryonic teratocarcinoma cells differentially expressed gene activity controlled by the human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type I (HTLV-I) long terminal repeats (LTRs) when differentiation was induced by the morphogen all-trans retinoic acid. The alterations occurred after commitment and before the appearance of the multiple cell types characteristic of these pluripotential cells. After commitment, gene activity controlled by the HIV-1 LTR markedly increased, whereas that controlled by the HTLV-I LTR decreased. Steady-state mRNA levels and nuclear run-on transcription indicated that the increased HIV-1-directed activity during differentiation occurred posttranscriptionally, whereas the decreased HTLV-I activity was at the transcriptional level. Phorbol esters did not cause commitment but strongly enhanced expression by both viral LTRs at the transcriptional level. A specific inhibitor of protein kinase C, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine, indicated that the enhanced activity involved the activation of protein kinase(s) C; altered cyclic nucleotide metabolism was apparently not involved. Differentiating cells gradually lost the ability to respond to phorbol ester stimulation. Experiments with a deletion mutant of the HIV-1 LTR suggested that this was due to imposition of negative regulation during differentiation that was not reversed by phorbol ester induction. Cycloheximide, with or without phorbol ester, slightly stimulated HIV-1-directed activity at the transcriptional level and massively increased the amounts of steady-state mRNA by posttranscriptional superinduction. It appeared, however, that new nuclear protein synthesis was required for maximal transcriptional stimulation by phorbol esters. Thus, changing cellular regulatory mechanisms influenced human retrovirus expression during human embryonic cell differentiation.

Negative regulation of viral enhancers in undifferentiated embryonic stem cells

Baculovirus Immediately Early 1, a Mediator for Homologous Regions Enhancer Function in Trans

Local Character of Readthrough Activation in Adenovirus Type 5 Early Region 1 Transcription Control

Regulation of endogenous retroviruses in murine embryonic stem cells and early embryos

Engineered External Guide Sequences Effectively Block Viral Gene Expression and Replication in Cultured Cells

Study on the Effect of Human CMV Early Transcriptional Enhancer on Human CEA Promoter

Kru euro ppel-like factor 5 rewires NANOG regulatory network to activate human naive pluripotency specific LTR7Ys and promote naive pluripotency

Transgenes Delivered by Lentiviral Vector Are Suppressed in Human Embryonic Stem Cells in A Promoter-Dependent Manner

Systematic Identification of Factors for Provirus Silencing in Embryonic Stem Cells.

Ribonuclease P-mediated inhibition of human cytomegalovirus gene expression and replication induced by engineered external guide sequences.

Transcription of two human genes from a bidirectional endogenous retrovirus promoter

Read-through Activation of Transcription in a Cellular Genomic Context.

Regulation of expression driven by human immunodeficiency virus type 1 and human T-cell leukemia virus type I long terminal repeats in pluripotential human embryonic cells

Dynamic Transcription of Distinct Classes of Endogenous Retroviral Elements Marks Specific Populations of Early Human Embryonic Cells.

New function of a well‐known promoter: Enhancer activity of minimal CMV promoter enables efficient dual‐cassette transgene expression

Viral integration promotes SV40T-induced immortalization by disturbing the expression of DNA/chromosome- and ECM-associated functional genes

Functions and Regulation of Endogenous Retrovirus Elements During Zygotic Genome Activation: Implications for Improving Somatic Cell Nuclear Transfer Efficiency

Cooperative action in eukaryotic gene regulation: Physical properties of a viral example

Endogenous reverse transcriptase and RNase H-mediated antiviral mechanism in embryonic stem cells

Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site

Hijacking of transcriptional condensates by endogenous retroviruses